Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insights into the place of fulvestrant for the treatment of advanced endocrine responsive breast cancer.

× No keyword cloud information.

3 in total

1. Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer.

Authors: Ewa Mrózek; Rachel Layman; Bhuvaneswari Ramaswamy; Larry Schaaf; Xiaobai Li; Susan Ottman; Charles L Shapiro
Journal: Clin Breast Cancer Date: 2012-04 Impact factor: 3.225

2. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.

Authors: Suleiman Massarweh; Yee L Tham; Jian Huang; Krystal Sexton; Heidi Weiss; Anna Tsimelzon; Amanda Beyer; Mothaffar Rimawi; Wei Yen Cai; Susan Hilsenbeck; Suzanne Fuqua; Richard Elledge
Journal: Breast Cancer Res Treat Date: 2011-07-27 Impact factor: 4.872

3. Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection.

Authors: Carmen Criscitiello; Debora Fumagalli; Kamal S Saini; Sherene Loi
Journal: Onco Targets Ther Date: 2010-12-17 Impact factor: 4.147

3 in total